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ABSTRACT
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of excessive immune activation that mimics and
occurs with other systemic diseases. A 35-year-old female presented with signs of viral illness at 13 weeks of
pregnancy and progressed to acute liver failure (ALF). We discuss the diagnosis of HLH and Kikuchi-Fujimoto
(KF) lymphadenitis in the context of pregnancy and ALF. HLH may respond to comorbid disease-specific ther-
apy, and more toxic treatment can be avoided.
INTRODUCTION
Hemophagocytic lymphohistiocytosis (HLH) is a rare disease associated with a dysregulated inflammatory
response and damage to multiple organs.1 There are several triggers for HLH,2 and successful treatment requires
prompt initiation of therapy.3
CASE REPORT
A 35-year-old Indian woman, gravida 2 para 1, presented at 13 weeks gestational age for upper respiratory infection
symptoms and painful left posterior cervical lymphadenopathy. She had no prior medical history. She was diag-
nosed with probable streptococcal pharyngitis and treated with amoxicillin clavulanate for 10 days.
The patient returned 6 weeks later with jaundice and fever. Her blood pressure was normal but her temperature
fluctuated between 36.78C and 418C. She had normal mental status, scleral icterus, a non-tender left cervical lymph
node, and a normal 20-week gravid abdomen. Liver biochemistries showed aspartate aminotransferase 2,781 U/L,
alanine aminotransferase 1,497 U/L, total bilirubin 11.6 mg/dL, alkaline phosphatase 108 U/L, and international nor-
malized ratio 1.6. Renal function, complete blood count, eosinophil count, and urine analysis were normal. She was
admitted for further evaluation. Her liver and obstetric ultrasounds were normal. An extensive infectious, auto-
immune, and metabolic work-up was negative, except for ferritin 4,567 ug/L and a nonspecific smooth muscle anti-
body titer of 1:40 (Table 1).
A transjugular liver biopsy was performed on hospital day 8 and showed active hepatitis, confluent pericentral ne-
crosis, and mild, diffuse lymphocytic inflammation (Figure 1). There was no microvesicular steatosis or hemophago-
cytosis. Fungal and bacterial cultures of the biopsy were negative. On hospital day 11, the patient became
hypothermic to 338C and hypotensive. She was transferred to the intensive care unit, volume resuscitated, and
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started on antibiotics. Her temperature rebounded to 38.78C
on the same day. Her alanine aminotransferase and aspartate
aminotransferase declined to 308 and 858 U/L, respectively,
but her bilirubin remained elevated at 16.3 mg/dL. Despite
vitamin K administration, her international normalized ratio
remained elevated at 1.7. Fibrinogen was low at 80 mg/dL.
Her triglyceride level was elevated at 307 mg/dL and her
ferritin increased to 10,024 ug/L. Platelets progressively
decreased to 67 x 109/L and hemoglobin dropped to 7.8 g/dL.
At this point, the patient met 4 out of 8 criteria for HLH
(Table 2): fever 38.58C, cytopenias in at least two lines, hy-
pertriglyceridemia, and ferritin >500 ng/mL. On hospital day
12, an excisional lymph node biopsy showed necrotizing
lymphadenitis suspicious for KF lymphadenitis (Figure 2).
There were no hemophagocytes in the biopsy.
Methylprednisolone was started on day 14 (1 g daily, intrave-
nous) to treat KF lymphadenitis.
On the same day she developed intermittent somnolence
and asterixis. Ammonia level was normal. Imaging of the head
was also normal. Electroencephalography showed no seizure
activity. Specific tests for HLH (NK cell activity and soluble
CD25) were performed, but results would not be available for
several days. Given concern for progression to ALF and with-
out an established HLH diagnosis, she was listed for liver
transplant. On hospital day 16, a bone marrow biopsy showed
evidence of hemophagocytosis (Figure 3). With this finding,
the patient met 5 out of 8 of the diagnostic criteria for HLH
(Table 2), which is the threshold for confirmation of HLH.
Figure 1. Liver biopsy. (A) High-power view of a central zone with conflu-
ent necrosis in zone 3 (400x magnification). (B) Hematoxylin and eosin
stain of a portal tract with mild lymphoplasmacytic inflammation but
intact ducts (400xmagnification).
Table 1. Negative/Normal Tests on Initial Work-Up
Serologies
Hepatitis A, B, C, E
Cytomegalovirus
Epstein-Barr
Herpes simplex virus
Human immunodeficiency virus
Bartonella henselae/Quintana
Leptospirosis
Leishmaniasis
Rapid plasma reagent
Bacterial blood cultures
Malaria smear
Quantiferon-TB-gold
Antinuclear antibodies
Anti-double stranded DNA
Liver-kidney microsomal antibodies
Immunoglobulin G
Ceruloplasmin
Table 2. HLH Clinical Diagnostic Criteria*
Five of the eight following criteria:
1. Fever38.58C
2. Splenomegaly
3. Cytopenias affecting 2 of the 3 lineages in the peripheral blood
Hemoglobin< 9 g/dL
Platelets< 100 x 103/mL
Neutrophils< 1 x 103/mL
4. Hypertriglyceridemia (fasting,>265 mg/dL) and or hypofibrinogenemia
(<150 mg/dL)
5. Hemophagocytosis in bone marrow, spleen, lymph nodes, or liver
6. No or absent natural killer cell activity
7. Ferritin> 500 ng/mL
8. Elevated sCD25 (a-chain of sIL-2 receptor)
*Adapted from Jordan et al (3).
Figure 2. Hematoxylin and eosin stain of lymph node biopsy with charac-
teristic agranulocytic necrosis with apoptotic debris, typical of Kikuchi-
Fujimoto disease (40x magnification).
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With no improvement with corticosteroids and the possibility
that the pregnancy was driving the inflammatory state, the
family elected to terminate the pregnancy. Prior to termina-
tion, the patient was started on dexamethasone (20 mg intra-
venous) and etoposide (75 mg/m2) on hospital day 16 for
treatment of HLH. Spontaneous abortion occurred the fol-
lowing day, an hour before scheduled termination. During the
next few days, the patient's bilirubin decreased to 6 mg/dL,
and her international normalized ratio normalized. Results
from the natural killer cell activity test were significantly low
at 4 LU30, and soluble CD25 results were significantly ele-
vated at 11,150 pg/mL.
Over the following 2 weeks, she received 2 additional doses
of etoposide. Her fevers resolved, ferritin decreased, and
soluble CD25 decreased to 2,085 pg/mL. Despite appropri-
ate treatment with etoposide and dexamethasone, the
patient's pancytopenia and liver biochemistries worsened on
day 42, and she died suddenly on day 48. The post mortem
examination revealed a proximal pulmonary embolus and a
small focus of residual HLH in the peripancreatic fat.
DISCUSSION
HLH is a disease associated with an extreme inflammatory
response and multiple organ damage, and is associated
with a poor prognosis and a mortality of 40%.1 In this
case, it was initially unclear whether the liver injury and
altered mental status were related to HLH. The patient's
elevated ferritin initially raised the possibility of HLH.
Hyperferritinemia, however, can be seen in other causes
of ALF,4 and neurologic symptoms have been described
in 33% of patients with HLH.5
The absence of hypertension and proteinuria, the timing of
her illness during the second trimester, and the liver biopsy
ruled out pregnancy-related causes of ALF. Liver ultrasound
did not demonstrate hepatic vein obstruction. Lymphoma and
leukemia were ruled out by biopsies. Amoxicillin-induced liver
injury was unlikely in the setting of a normal eosinophil count,
lack of cholestasis or duct damage on liver biopsy, and the
more probable diagnosis of HLH.
In a review of HLH cases, an associated disease was identified
96% of the time, including viral infection (35%) and hemato-
logical neoplasm (45%).1 Some cases of HLH will respond to
disease-specific therapy, and treatment with etoposide and
corticosteroids can be avoided.3
Kikuchi-Fujimoto lymphadenitis is an idiopathic disease that is
predominantly found in young women.6 Most patients with
KF lymphadenitis have localized adenopathy of the cervical
chain and a third of patients have fever. KF lymphadenitis is
usually self-limited, with adenopathy disappearing in several
weeks. In this case, we decided to treat with corticosteroids
in light of the extranodal manifestations.
HLH diagnostic criteria share some common features with KF
disease (Table 2). There are 10 published cases of KF lymph-
adenitis associated with HLH,7-14 8 cases of KF diagnosed dur-
ing pregnancy,6 and HLH during pregnancy has been
reported in 14 cases.7,15,16 Out of the 14 cases of HLH in preg-
nancy, one bears some similarity to our patient's presentation,
as she was also diagnosed with KF disease.7 In that case, early
delivery was initiated at 30 weeks; the patient died but the
infant survived.
Due to our patient's rapid deterioration, we listed her for liver
transplantation (LT) prior to confirming HLH diagnosis. We
were aware of the high mortality following LT for HLH but we
considered LT until the diagnosis was confirmed.17 The
patient's liver function recovered rapidly following spontane-
ous abortion and institution of HLH-directed therapy, there-
fore LT was no longer indicated. Liver transplantation
shouldn't be considered as a treatment of HLH, as the liver
failure is only a manifestation of the general HLH inflamma-
tory storm and not the culprit.1 Two cases of LT for HLH are
found in the literature; both patients died from HLH recur-
rence less than 2 months after transplant.17-18
Thorough evaluation confirmed KF lymphadenitis and
HLH, both of which we believe were induced by preg-
nancy-related immune dysregulation. We believe the
spontaneous abortion was an important factor leading to
the patient's clinical improvement; it was unlikely due to
corticosteroids alone and too soon to be explained by
etoposide given 1 day earlier.
Although our patient's liver function improved, she died from
a massive pulmonary embolism, probably related to
Figure 3. Hematoxylin and eosin stain of bone marrow biopsy with hemo-
phagocytosis in the center of the field in which a red cell indents a macro-
phage nucleus (1,000xmagnification).
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hypercoagulability associated with HLH, peripartum state,
and immobility. The worsening of her liver tests and pancyto-
penia prior to her death was probably due to persistent HLH
as noted on autopsy, a disappointing but not surprising result
given the poor prognosis associated with HLH.
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